ReviewAdvances and technical standards in neurosurgery2026
Decisional Tree for Pineal Tumors.
Review in Advances and technical standards in neurosurgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pineal tumors are rare and it is important that they have to be treated by actors involved in their care. The first thing to do is the realization of the routine radiological studies necessary to establish if the tumor is located only in the pineal region or if there is bifocal localization or if the tumor is associated with a metastatic diffusion. Cerebral MRI represents the golden standard for diagnosis, associated, especially in children, to a spinal study. The study of pineal markers, the alpha protein, total human choroid gonadotrophin (hCG), and the free beta HCG, in the blood and in the CSF is of paramount importance to avoid unnecessary surgery because their presence means that we are in the face of a germ cell tumor. The age of patients is an important factor to consider because some lesions are more frequent in the pediatric age, in contrast to other tumors, which are more frequent in adult age. The decision of the choice of treatment sometimes can be difficult and for this the discussions in multidisciplinary concentration groups are necessary and these discussions should be organized also in emergencies to ensure all patients, at any time, are guaranteed of the best treatment.Surgery has a great place for treatment of benign lesion, while chemotherapy and radiotherapy have to be reserved for more malignant tumors according to the definitive histological and genetic studies of the lesions.
Indexed as
Identifiers
42115457What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.